Home msd
 

Keywords :   


Tag: msd

MSD Animal Health Receives Marketing Authorization from European Commission for BRAVECTO (fluralaner)

2014-02-17 09:00:00| Merck.com - Corporate News

Dateline City: SUMMIT, N.J. First Chewable Tablet Approved for Fleas and Ticks in Dogs Effective for 12 Weeks (8 Weeks for Rhipicephalus sanguineus Ticks) SUMMIT, N.J.--(BUSINESS WIRE)--MSD Animal Health, known as Merck Animal Health in the United States and Canada, announced today that following a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has granted marketing authorization for the veterinary medicinal product BRAVECTO (fluralaner) chewable tablets for dogs (112.5 mg, 250 mg, 500 mg, 1000 mg, 1400 mg). Language: English Contact: Media:MSD Animal HealthAmy Firsching, +1 908-473-6357orPam Eisele, +1 908-423-5042 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: health marketing european animal

 

MSD Animal Health, Utrecht University Partner up to Discover PED Vaccine

2014-02-07 01:00:00| ThePigSite - Industry News

US & NETHERLANDS - MSD Animal Health (known as Merck Animal Health in the USA and Canada) announced that it has entered into a research agreement with Utrecht University to test leads towards a vaccine for Porcine Epidemic Diarrhea Virus. Research has already begun under the agreement, which will last 12 months.

Tags: health university partner animal

 
 

MSD Animal Health Receives Positive Opinion from European Medicines Agency for BRAVECTO (fluralaner)

2013-12-17 10:00:00| Merck.com - Corporate News

Dateline City: SUMMIT, N.J. New Chewable Tablet Treatment for Fleas and Ticks in Dogs Effective For 12 Weeks (8 weeks for Rhipicephalus sanguineus ticks) SUMMIT, N.J.--(BUSINESS WIRE)--MSD Animal Health (known as Merck Animal Health in the United States and Canada) today announced that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency has adopted a positive opinion, recommending the granting of a marketing authorization for the veterinary medicinal product BRAVECTO (fluralaner) chewable tablets for dogs (112.5 mg, 250 mg, 500 mg, 1000 mg, 1400 mg). Language: English Contact: MSD Animal HealthAmy Firsching, +1 908 473 6357amy.firsching@merck.comorPam Eisele, +1 908 423 5042pamela_eisele@merck.com Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: health positive opinion agency

 

MSD Animal Health Presents Important Data at Asian Pig Veterinary Society Congress

2013-09-24 02:00:00| ThePigSite - Industry News

VIET NAM - MSD Animal Health (known as Merck Animal Health in the USA and Canada) announced that data related to its swine products and product-related services will be presented at the 6th Asian Pig Veterinary Society (APVS) Congress on 23 to 25 September 2013 in Ho Chi Minh City.

Tags: data health important society

 

MSD Statement Regarding CHMP Review of Incretin-Based Therapies for Type 2 Diabetes, Including Sitagliptin

2013-07-26 16:16:00| Merck.com - Product News

Dateline City:  WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck Sharpe and Dohme (MSD), known as Merck in the United States and Canada, issued the following statement regarding the conclusion of the European Medicines Agencys (EMA) Committee for Medicinal Products for Human Use (CHMP) review of GLP-1, or incretin-based, therapies, including sitagliptin. Language:  English Contact:  MSDMedia:Pam Eisele, +1-908-423-5042Michael Close, +1-267-305-1211Investor:Carol Ferguson, +1-908-423-4465 Ticker Slug:  Ticker: MRK Exchange: NYSE read more

Tags: type including review statement

 

Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9]